Article | £200m+ invested in Babraham Campus companies, what lies ahead?

July 14, 2021 | Featured on Business Weekly

babraham_derek_jones 1200x755

Derek Jones, Chief Executive of the Babraham Research Campus


CAMBRIDGE, Wednesday 14 July 2021 —On Wednesday 14 July 2021, attended The Babraham Investor Conference 2021 (BIC), an event for investors focusing on early-stage and scale-up life science and med-tech companies. Co-Founder Florian Schuster was the second scale-up speaker.

Derek Jones, Chief Executive of the Babraham Research Campus opened the event by outlining how the Campus directly impacts the investor community: “Research has shown that investors see a 7.2 x return on investments on average in Campus companies.”

Florian revealed how is coding human cells for health, to precision engineer the next generation of medicine.

Florian Schuster Co-Founder, CFO and COO said:

Florian round image png 
“We are solving the manufacturing problem of human cells which allows us to overcome the major problems our sector is currently facing: the reproducibility issues in scientific research, the translational gap in drug development, and to make cell therapies consistent and scalable.” has raised more than £50 million in seed and Series A funding.

Full article access